Manufacturing

Trust-based CDMO partnerships are becoming essential to accelerate injectable drug development, manage risk, and ensure resilient biopharma supply.

FDA commissioner warns US trial startup delays may cede early drug development to China, urging IND and IRB process reforms amid global competitions.

A $1 Billion Pennsylvania cell therapy site investment bolsters domestic manufacturing, creating 500 skilled biomanufacturing jobs.

PharmTech spoke with women working in the pharmaceutical industry about the innovations they are seeing in bio/pharma and the role women play in the development of critical treatments for patients.

Fresenius Kabi and Phlow partner to onshore US epinephrine production, securing the domestic supply chain for essential medicines.

Integrated CDMO networks streamline complex drug development across advanced modalities like ADCs.

The PreCheck Pilot Program is designed to strengthen the US pharmaceutical supply chain by increasing regulatory predictability and streamlining the assessment of new domestic manufacturing sites.

The ROSS CDA-200 optimizes viscous pharmaceutical batches via independent agitation, vacuum, and thermal control.

WuXi Biologics and HanchorBio partner to accelerate multi-functional fusion protein translation via end-to-end CMC and GMP services.

Raj Puri, CCO, Argonaut Manufactoring, provides key insight on navigating tariffs, supply redundancy, and the risks of compressed timelines.

At the Pharmapack Europe 2026 awards ceremony, Pharmapack announced it is expanding the event to Singapore in November 2026. This year’s award winners were also announced.

ACG’s new SuperPod reduces blister size and boosts efficiency and sustainability for moisture-sensitive drug products.

The half-day workshop will explore regulatory compliance and environmental sustainability.

Industry experts discuss the standout packaging trends from 2025 that will influence the industry’s future.

Sharp increases European injectable assembly and secondary packaging capacity to support the rising demand for pre-filled syringes and autoinjectors.

The company will be highlighting its PharmaGuard recyclable blister solution, MedGuard line, and MedHub procurement service.

Automation and supply-chain security of single-use systems are crucial for industrializing cell and gene therapy manufacturing.

To combat growth and pricing pressures, companies are auditing their supply chains and API material providers.

The company is adding a second production line at its Etten-Leur facility in The Netherlands to meet customer needs.

Meri Beckwith, Co-CEO of Lindus Health, provides a look at how trends that developed in 2025 will impact the pharmaceutical industry in 2026.

FUJIFILM Irvine Scientific has changed its name to FUJIFILM Biosciences to better align with the company’s work in cell culture media manufacturing.

ROSS’s DCB-5 Double Cone Tumble Blender can handle high-density materials and provides repeatable homogeneity and powder blending properties, according to the company.

David Basile, VP Technical Operations, Americas, Hovione, highlights some common mistakes made by pharmaceutical companies when maintaining manufacturing facilities and equipment.

Pharmaceutical Technology®’s quality experts, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs company, and Siegfried Schmitt, PhD, vice president, Technical at Parexel discuss how pharmaceutical manufacturing training has evolved over the years and how the influx of new facilities is demanding a skilled workforce.